TokenPost·
Lunai Bioworks Plans Nasdaq Delisting After $9.02 Million Deficit
$9.02M
stockholders' deficit
Trading in its common stock is expected to be suspended Oct. 30, with the delisting expected to take effect around Nov. 12.
More news
- UnchainedPolymarket Pushes Out Marketing Chief Modabber, a Longtime Friend of CEO Coplan: Report
- TokenPostBank of Korea Manual Outlines Monthly Crypto Balance Reporting Rules
- TokenPostTRON Makes GreatVoyage-v4.8.2.4 Mandatory for Node Operators
- TokenPostChangeNOW Executive Describes Bitcoin Cross-Chain Integration Talks
- TokenPostNAGA Gives Q4 Risk-Off Scenario 50% Weight in Market Outlook
- TokenPostMonero Futures Open Interest Exceeds $300 Million as XMR-Denominated Measure Hits Five-Week High